期刊文献+

晚期糖基化终产物和同型半胱氨酸对内皮细胞的协同损伤作用 被引量:10

Co-injury effects of advanced Glycation end products and Homocysteine on endothelial cells
下载PDF
导出
摘要 目的探讨两种尿毒症毒素晚期糖基化终产物(advanced glycation end products,AGE)和同型半胱氨酸(homocysteine,Hcy)在致血管内皮细胞损伤的过程中是否具有协同作用。方法不同浓度的AGE修饰牛血清白蛋白(AGE-BSA)和Hcy单独或联合作用于人脐静脉内皮细胞株ECV304细胞,检测各组上清液NO浓度和脂质过氧化终产物丙二醛(MDA)含量及细胞凋亡百分率。结果AGE+Hcy联合干预组的细胞凋亡率明显高于单独AGE和Hcy干预组(P<0.01),MDA含量也显著高于AGE干预组(P<0.05)和Hcy干预组(P<0.01),联合组干预组NO浓度则明显低于单独干预组(P<0.01)。结论AGE和Hcy均参与了血管内皮细胞的损伤,两者具有协同效应,上述效应可能与氧化应激有关,推测终末期肾病(ESRD)患者AGE和Hcy的升高可能是加速该人群动脉粥样硬化发生发展的重要因素。 [Objective] To investigate whether advanced Glycation end products (AGE) and Homocysteine (Hey) had co-effects on the injury of vascular endothelial cells. [Methods] ECV304 cell line, derived from human umbilical vein endothelial cells, were cultured in vitro with AGE modified bovine serum albumin (AGE-BSA) or Hey respectively and both together. Then 20 μl of 5 mg/mL MTT were added and the optical density (OD) at each concentration was determined in order to calculate the proliferation-inhibiting rate of cells. NO levels and MDA contents- results of lipid peroxidation in the supernatant were determined by using spectrophotometer. The ratio of apoptosis was assessed by Hoechst staining and flow cytometry techniques. [Results] The proliferation-inhibiting rates and apoptosis rates in AGE+Hcy were both significantly higher than those in the AGE group (P 〈0.01) and Hcy group (P 〈0.01). The MDA contents in AGE+Hcy group were also significantly higher than those in the AGE group (P 〈0.05) and Hcy group (P 〈0.01). But the NO levels in co-intervention group were significantly lower than those in solo intervention groups (P 〈0.01). [Conclusion] Both AGE and Hcy can damage the vascular endothelial cells and they have co-injury effects on these cells, which may be related to oxidative stress and involved in the pathogenesis of atherosclerosis of the end stage renal disease (ESRD) patients.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第11期1552-1556,共5页 China Journal of Modern Medicine
关键词 晚期糖基化终产物 同型半胱氨酸 内皮细胞 终末期肾病 advanced Glycation end products Homocystein endothelial cells end stage renal disease
  • 相关文献

参考文献13

  • 1FOLEY RN, PARFREY PS, SARNAK MJ. Epidemiology of cardiovascular disease in chronic renal disease [J]. J Am Soc Nephrol, 1998, 9(12): S16-23.
  • 2张卫茹,侯凡凡,刘尚喜,郭志坚,周展眉,王国保,富宁,刘志强,王力,周玫.晚期糖基化终产物通过氧化应激加速动脉粥样硬化斑块形成[J].中华医学杂志,2004,84(13):1066-1070. 被引量:28
  • 3AU-YEUNG KK, WOO CW, SUNG FL, et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress[J]. Circ Res, 2004, 94(1): 28-36.
  • 4MAKITA Z, VLASSARA H, CERAMI A, et al. Immunochemical detection of advanced glycosylation end products in vivo [J]. J Biol Chem, 1992, 267(8): 5133-5138.
  • 5黄征宇,姚康宝,黄映红,何峻.血浆同型半胱氨酸水平与冠状动脉病变相关性分析[J].中国现代医学杂志,2004,14(5):63-64. 被引量:39
  • 6ADAMS MR, KINLAY S, BLAKE GJ, et al. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes[J]. Annu Rev Med, 2000, 51: 149-167.
  • 7WAUTIER MP, CHAPPEY O, CORDA S, et al. Activation of NADPH oxidese by AGE links oxidant stress to altered gene expression via RAGE [J]. Am J Physiol Endocrinol Metab, 2001, 280(5): E685-694.
  • 8DEUTHER CW, LOSKE C, SCHINZEL R, et al. Advanced glycation end products change glutathione redox status in SH-SY5Y human neuroblastoma cells by a hydrogen peroxide dependent mechanicsm[J]. Neurosci Lett, 2001, 312(1): 29-32.
  • 9UHLMANN S, REZZOUG K, FRIEDRICHS U, et al. Advanced glycation end products quench nitric oxide in vitro [J]. Graefes Arch Clin Exp Ophthalmol, 2002, 240(10): 860-866.
  • 10ASAHI K, ICHIMORI K, NAKAZAWA H, et al. Nitric oxide inhibits the formation of advanced glyeation end products [J]. Kidney Int, 2000, 58(4): 1780-1787.

二级参考文献45

  • 1申洪,陆药丹.免疫组织化学染色的定量方法研究[J].生物医学工程学杂志,1993,10(4):281-284. 被引量:127
  • 2[1]Wood D.Estabilished and emerging cardiovascular risk factor[J].Am Heart J,2001,141(2 supple):49-57.
  • 3[2]Chambers JC,Ueland DM.Obeid OA,et al.Improved vascular endothelial function after oral B vitamins:An effect mediated through reduced concentrations of free plasma homocysteine [J].Circulation,2000,102:2479-2483.
  • 4Odctti P,Forgarty J,Sell DR,et al. Chromatographic quantitition of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes, 1992,41: s153-159.
  • 5Miyata T,Kurokawa K,van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int,2000,58: 120-125.
  • 6Lyons TJ: Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol, 1993, 71: 26B-31B.
  • 7Josse C,Boelaert JR,Best-Belpomme M,et al. Importance of post-transcriptional regulation of chemokine genes by oxidative stress. Biochem J, 2001,360: 321-333.
  • 8Hou FF,Boyce J,Chertow GM,et al. Aminoguanidine inhibits advanced glycation end products formation on beta2-microglobulin. J Am Soc Nephrol,1998 , 9: 277-283.
  • 9鄂征. 内皮细胞培养. 见:鄂征主编,组织培养和分子细胞学技术. 北京:北京出版社, 1999.125-126.
  • 10庞战军. Griess 试剂法. 见:庞战军,陈瑗,周玫著,自由基医学研究方法,224-226.

共引文献119

同被引文献88

引证文献10

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部